Sonova Holding AG (LON:0QPY)
224.61
-0.29 (-0.13%)
At close: Aug 13, 2025
Sonova Holding AG Revenue
In the fiscal year ending March 31, 2025, Sonova Holding AG had annual revenue of 3.87B CHF with 6.58% growth. Sonova Holding AG had revenue of 2.03B in the half year ending March 31, 2025, with 7.42% growth.
Revenue
3.87B CHF
Revenue Growth
+6.58%
P/S Ratio
3.64
Revenue / Employee
210.46K CHF
Employees
18,366
Market Cap
12.33B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 3.87B | 238.50M | 6.58% |
Mar 31, 2024 | 3.63B | -111.50M | -2.98% |
Mar 31, 2023 | 3.74B | 374.50M | 11.13% |
Mar 31, 2022 | 3.36B | 762.00M | 29.29% |
Mar 31, 2021 | 2.60B | -315.00M | -10.80% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
Oxford Nanopore Technologies | 183.19M |
HUTCHMED (China) | 439.54M |